PAG neuronal NMDARs activation mediated morphine-induced hyperalgesia by HMGB1-TLR4 dependent microglial inflammation

Jingjing Mo1, Zijing Lu2, Jialing Peng3

  • 1Department of Neurology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, China.

PubMed

Insights

Chronic morphine use causes opioid-induced hyperalgesia (OIH) via Toll-like receptor 4 (TLR4) activation in the periaqueductal gray. This pathway involves High-mobility group box 1 (HMGB1) and microglia, leading to neuronal hyperexcitability and OIH.

Area of Science:

  • Neuroscience
  • Immunology
  • Pharmacology

Background:

  • Opioid-induced hyperalgesia (OIH) is a significant clinical challenge limiting morphine's analgesic efficacy.
  • The precise mechanisms underlying OIH, particularly the roles of Toll-like receptor 4 (TLR4) and glutamate receptors in the periaqueductal gray (PAG), remain incompletely understood.

Purpose of the Study:

  • To elucidate the association between TLR4 and N-methyl-D-aspartate Receptors (NMDARs) activation in the PAG during OIH.
  • To investigate the role of microglia and specific molecular pathways in morphine-induced hyperalgesia.

Main Methods:

  • Utilized a mouse model of OIH, observing microglia activation, TLR4/p65 NF-κB signaling, and NMDAR subunit phosphorylation in the PAG.
  • Employed cell cultures (BV2, N2A) to examine TLR4 activation by High-mobility group box 1 (HMGB1) and its downstream effects on NMDARs.
  • Intervened using TLR4 inhibition, knockdown, and knockout (Lentivirus-GFP-TLR4 shRNA) to assess their impact on OIH.

Main Results:

  • Morphine induced microglia activation, increased TLR4/p65 NF-κB, and pro-inflammatory cytokines in the PAG and BV2 cells.
  • Morphine activated TLR4 via HMGB1, not MD2, leading to microglia-derived inflammation that phosphorylated NMDAR subunits (NR1, NR2B) in adjacent neurons.
  • TLR4 knockout in the PAG reversed these molecular changes and significantly alleviated OIH symptoms.

Conclusions:

  • Morphine-induced OIH involves TLR4 activation in PAG microglia, mediated by HMGB1.
  • Activated microglia release inflammatory factors that phosphorylate NMDARs in neurons, increasing excitability and contributing to OIH.
  • Targeting the TLR4/NMDAR pathway in the PAG presents a promising therapeutic strategy for managing OIH.